ReGen III Corp. (TSXV:GIII), a Canadian clean tech company pioneering the upcycling of used motor oil into high value Group III base oils through its patented ReGen™ technology, is sitting with us ...

Welcome to episode 15 of The 5-Minute Investor Podcast, where Stockhouse columnists Jonathon Brown and Trevor Abes each deliver a 2.5-minute stock pick related to recent news stories with investment ...

Get a summary of what's been happening on the Stockhouse forums on a weekly basis. Article highlights key forums to watch and explore.

Ten-bagger Founders Metals (TSXV:FDR) successfully completed all requirements under stage 2 of its option on the 20,000-hectare Antino gold project in Suriname, increasing its stake from 51 to 70 per ...

VANCOUVER, BRITISH COLUMBIA – TheNewswire - June 2, 2025 (TSXV: PINN, OTC: NRGOF, Frankfurt: P9J) – Pinnacle Silver and Gold Corp. (" Pinnacle" or the “ Company") is pleased to announce that ...

WARSAW, Ind., April 25, 2025 (GLOBE NEWSWIRE) -- Lakeland Financial Corporation (Nasdaq Global Select/LKFN), parent company of Lake City Bank, today reported net income of $20.1 million for the three ...

Vancouver, British Columbia, May 11, 2025 (GLOBE NEWSWIRE) -- Pan American Silver Corp. (NYSE: PAAS) (TSX: PAAS) ("Pan American") and MAG Silver Corp. (NYSEAM:MAG) (TSX:MAG) ("MAG") are pleased to ...

Westhaven Gold (TSXV:WHN) intends to raise C$3.16M, including investments from Eric Sprott and Earthlabs (TSXV:SPOT).

Conflict of interest Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter ...

Create a free multiple transaction based Portoflio of all of your investments including stocks, funds, and cash. Track gains and losses over time by tracking every buy and sell transaction.

MediPharm Labs (TSX:LABS) has begun production for its novel cannabis metered dose inhalers (MDIs) tailored for the EU and UK markets.

New clinical results show sustained CRi, deep bone marrow responses, and encouraging survival in FLT3-mutant AML patients, including those previously treated with gilteritinib REDWOOD CITY, Calif., ...